{"id":"https://openalex.org/W2396539550","doi":"https://doi.org/10.47102/annals-acadmedsg.v28n6p775","title":"A Pilot Study of the Efficacy and Tolerability of Intralesional Recombinant Human Beta-Interferons in Cervical Intraepithelial Neoplasia","display_name":"A Pilot Study of the Efficacy and Tolerability of Intralesional Recombinant Human Beta-Interferons in Cervical Intraepithelial Neoplasia","publication_year":1999,"publication_date":"1999-11-15","ids":{"openalex":"https://openalex.org/W2396539550","doi":"https://doi.org/10.47102/annals-acadmedsg.v28n6p775","mag":"2396539550","pmid":"https://pubmed.ncbi.nlm.nih.gov/10672385"},"language":"en","primary_location":{"id":"doi:10.47102/annals-acadmedsg.v28n6p775","doi":"https://doi.org/10.47102/annals-acadmedsg.v28n6p775","is_oa":false,"landing_page_url":"https://doi.org/10.47102/annals-acadmedsg.v28n6p775","pdf_url":null,"source":{"id":"https://openalex.org/S134891020","display_name":"Annals of the Academy of Medicine Singapore","issn_l":"0304-4602","issn":["0304-4602","2972-4066"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310317082","host_organization_name":"Academy of Medicine, Singapore","host_organization_lineage":["https://openalex.org/P4310317082"],"host_organization_lineage_names":["Academy of Medicine, Singapore"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Academy of Medicine, Singapore","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079019918","display_name":"Mike Katesmark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Katesmark","raw_affiliation_strings":["Department of Obstetrics and Gynaecology, King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040468298","display_name":"Sam Coulter-Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Coulter-Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075728849","display_name":"Kate M. Reynolds","orcid":"https://orcid.org/0000-0002-9292-474X","observed_orcids":["https://orcid.org/0000-0002-9292-474X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Reynolds","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109996051","display_name":"F. E. Lawton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Lawton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.29543017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"28","issue":"6","first_page":"775","last_page":"777"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cervical-intraepithelial-neoplasia","display_name":"cervical intraepithelial neoplasia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/recombinant-human-interferon","display_name":"recombinant human interferon","score":0.9309999942779541},{"id":"https://openalex.org/keywords/interferon-therapy","display_name":"interferon therapy","score":0.4429999887943268},{"id":"https://openalex.org/keywords/transformation-zone","display_name":"transformation zone","score":0.5699999928474426},{"id":"https://openalex.org/keywords/lletz","display_name":"LLETZ","score":0.7480000257492065},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9509999752044678},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9759540557861328},{"id":"https://openalex.org/C2777343196","wikidata":"https://www.wikidata.org/wiki/Q196788","display_name":"Cervical intraepithelial neoplasia","level":4,"score":0.7695402503013611},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6270807385444641},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.49374207854270935},{"id":"https://openalex.org/C2779112978","wikidata":"https://www.wikidata.org/wiki/Q423417","display_name":"Imiquimod","level":2,"score":0.4848857820034027},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.47565194964408875},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4123009145259857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40764033794403076},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35156190395355225},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3396470546722412},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.3195529580116272},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.2523399889469147},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2320202887058258},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.08786380290985107},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002578","descriptor_name":"Uterine Cervical Dysplasia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002578","descriptor_name":"Uterine Cervical Dysplasia","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015552","descriptor_name":"Injections, Intralesional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.47102/annals-acadmedsg.v28n6p775","doi":"https://doi.org/10.47102/annals-acadmedsg.v28n6p775","is_oa":false,"landing_page_url":"https://doi.org/10.47102/annals-acadmedsg.v28n6p775","pdf_url":null,"source":{"id":"https://openalex.org/S134891020","display_name":"Annals of the Academy of Medicine Singapore","issn_l":"0304-4602","issn":["0304-4602","2972-4066"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310317082","host_organization_name":"Academy of Medicine, Singapore","host_organization_lineage":["https://openalex.org/P4310317082"],"host_organization_lineage_names":["Academy of Medicine, Singapore"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Academy of Medicine, Singapore","raw_type":"journal-article"},{"id":"pmid:10672385","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10672385","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Academy of Medicine, Singapore","raw_type":"Clinical Trial"},{"id":"mag:2396539550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10672385","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7217747905","https://openalex.org/W1595985677","https://openalex.org/W2342010439","https://openalex.org/W2117037332","https://openalex.org/W2408151135","https://openalex.org/W2010230397","https://openalex.org/W2410738293","https://openalex.org/W2381645400","https://openalex.org/W2043906060","https://openalex.org/W2412196134"],"abstract_inverted_index":{"Beta-interferons":[0],"possess":[1],"anti-viral,":[2],"cell":[3],"proliferation":[4],"inhibition":[5],"and":[6,38,70,85,94,132,148,185],"immunomodulatory":[7],"characteristics":[8],"which":[9,123],"may":[10,24,214],"be":[11],"of":[12,17,98,115,126,221,227],"use":[13],"in":[14,167,177,182,188,197,218],"the":[15,46,79,99,116,199,219],"treatment":[16,81,127],"cervical":[18,32,47,83],"intraepithelial":[19],"neoplasia":[20],"(CIN).":[21],"Intralesional":[22],"administration":[23],"avoid":[25,235],"systemic":[26],"side":[27],"effects.":[28],"Twenty-six":[29],"women":[30],"with":[31,113],"punch":[33],"biopsy":[34,86],"proven":[35],"CIN":[36,222],"I":[37],"II":[39],"were":[40,87,159],"treated":[41],"by":[42],"interferon":[43],"injection":[44],"into":[45],"transformation":[48,100],"zone":[49,101],"according":[50],"to":[51,89,141,234],"three":[52,76],"dosage":[53],"regimens--6":[54],"million":[55,64,72],"international":[56],"units":[57],"(IU)":[58],"weekly":[59,66],"for":[60,67,75,143,207,224],"six":[61,68,106,146],"weeks,":[62],"9":[63],"IU":[65,73],"weeks":[69],"12":[71,168],"bi-weekly":[74],"weeks.":[77],"At":[78],"last":[80],"visit,":[82],"cytology":[84],"taken":[88],"ensure":[90],"no":[91],"disease":[92],"progression":[93],"large":[95],"loop":[96],"excision":[97],"(LLETZ)":[102],"was":[103,111,165,180],"carried":[104],"out":[105],"months":[107,147],"after":[108],"treatment.":[109],"Therapy":[110],"well-tolerated":[112],"93%":[114],"scheduled":[117,157],"156":[118],"treatments":[119,158],"given.":[120],"Side":[121],"effects":[122],"caused":[124],"cessation":[125],"included":[128],"severe":[129],"myalgia,":[130],"headaches":[131],"prolonged":[133],"flu-like":[134],"symptoms.":[135],"The":[136],"2":[137,150,189],"patients":[138,151,169,184],"who":[139,152],"failed":[140],"attend":[142],"LLETZ":[144,163],"at":[145],"another":[149],"received":[153],"fewer":[154],"than":[155,204],"five":[156],"excluded":[160],"from":[161],"analysis.":[162],"histology":[164],"negative":[166],"(54%),":[170],"showed":[171],"inflammatory":[172],"changes":[173],"or":[174,209],"squamous":[175],"metaplasia":[176],"4":[178,183],"(18%),":[179],"unchanged":[181],"had":[186],"progressed":[187],"(10%).":[190],"Whilst":[191],"intralesional":[192],"beta-interferon":[193],"clearly":[194],"has":[195],"activity":[196],"CIN,":[198],"response":[200],"rate":[201],"is":[202,231],"less":[203],"that":[205],"seen":[206],"excisional":[208],"ablative":[210],"procedures.":[211],"Nevertheless,":[212],"it":[213],"have":[215],"a":[216,232],"role":[217],"management":[220],"where,":[223],"medical":[225],"reasons":[226],"patient":[228],"preference,":[229],"there":[230],"desire":[233],"surgical":[236],"therapy.":[237]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}